1. Home
  2. ASPN vs MNMD Comparison

ASPN vs MNMD Comparison

Compare ASPN & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • MNMD
  • Stock Information
  • Founded
  • ASPN 2001
  • MNMD 2019
  • Country
  • ASPN United States
  • MNMD United States
  • Employees
  • ASPN N/A
  • MNMD N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • MNMD Pharmaceuticals and Biotechnology
  • Sector
  • ASPN Consumer Discretionary
  • MNMD Health Care
  • Exchange
  • ASPN Nasdaq
  • MNMD Nasdaq
  • Market Cap
  • ASPN 486.5M
  • MNMD 541.7M
  • IPO Year
  • ASPN 2014
  • MNMD N/A
  • Fundamental
  • Price
  • ASPN $6.16
  • MNMD $6.80
  • Analyst Decision
  • ASPN Strong Buy
  • MNMD Strong Buy
  • Analyst Count
  • ASPN 10
  • MNMD 8
  • Target Price
  • ASPN $21.78
  • MNMD $26.29
  • AVG Volume (30 Days)
  • ASPN 1.4M
  • MNMD 1.2M
  • Earning Date
  • ASPN 08-06-2025
  • MNMD 08-12-2025
  • Dividend Yield
  • ASPN N/A
  • MNMD N/A
  • EPS Growth
  • ASPN N/A
  • MNMD N/A
  • EPS
  • ASPN N/A
  • MNMD N/A
  • Revenue
  • ASPN $436,921,000.00
  • MNMD N/A
  • Revenue This Year
  • ASPN N/A
  • MNMD N/A
  • Revenue Next Year
  • ASPN $24.31
  • MNMD N/A
  • P/E Ratio
  • ASPN N/A
  • MNMD N/A
  • Revenue Growth
  • ASPN 51.90
  • MNMD N/A
  • 52 Week Low
  • ASPN $4.16
  • MNMD $4.70
  • 52 Week High
  • ASPN $33.15
  • MNMD $10.44
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 52.87
  • MNMD 47.19
  • Support Level
  • ASPN $5.75
  • MNMD $6.40
  • Resistance Level
  • ASPN $6.36
  • MNMD $6.91
  • Average True Range (ATR)
  • ASPN 0.31
  • MNMD 0.41
  • MACD
  • ASPN -0.00
  • MNMD -0.08
  • Stochastic Oscillator
  • ASPN 62.13
  • MNMD 39.67

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: